Recent evidence revealed that, at every level of signal transduction, the ER and growth factor-signaling pathways crossed and directly interacted [51], indicating ER–growth factor synergism documented in both normal breast development and, more crucially, in breast cancer progression and antiestrogen resistance. Here, ESR1 is linked to breast cancer.